ESR2 and breast carcinoma: Multiple reports show that estrogen exposure to ERα expressing breast cancer cells lead to an increase in proliferation, while exposure to ERβ expressing cells, either alone or in combination with ERα, results in inhibition of cellular proliferation [42], [43], [44].